Neuromuscular Blockers In ARDS
b'In this episode of Critical Matters, we will discuss the role of early neuromuscular blockers in the treatment of severe ARDS.\\n\\nOur guest is Dr. Arthur Slutsky, Professor of Medicine, Surgery and Biomedical Engineering at the University of Toronto. Dr. Slutsky is a world-renowned clinician and investigator with a special interest in ARDS. We will review a recently published clinical trial and discuss its result within the context of available evidence.\\n\\nAdditional Resources:\\nNeuromuscular Blockers in Early Acute Respiratory Distress Syndrome: https://bit.ly/2YwXxnG\\nNeuromuscular Blocking Agents in ARDS: https://bit.ly/2KmMZiA\\nEarly Neuromuscular Blockade in the Acute Respiratory Distress Syndrome: https://bit.ly/2ROMJea\\nEarly Paralytic Agents for ARDS? Yes, No, and Sometimes: https://bit.ly/2ZONDuB\\n\\nBooks Mentioned in this Episode:\\nNudge: Improving Decisions About Health, Wealth and Happiness by Richard H. Thaler and Cass R. Sunstein: https://amzn.to/2Kv75pD\\nMisbehaving: The Making of Behavioral Economics by Richard H. Thaler: https://amzn.to/2YRm5Dc\\nBad Blood: Secrets and Lies in a Silicon Valley Startup by John Carreyrou: https://amzn.to/2MPDjyN'